Biovail Corp. founder Eugene Melnyk said he is considering purchasing the biotech firm or selling his stakes amid his disappointment on the direction of the firm under the current management. The company expressed its commitment to improving its shareholder value and said it will evaluate any proposals from Melnyk, other shareholders or future investors.

Related Summaries